Ticker | $ Bought |
---|---|
verona pharma plc | 84,568,100 |
globus med inc | 80,394,100 |
zai lab ltd | 65,713,800 |
rapt therapeutics inc | 18,587,100 |
corvus pharmaceuticals inc | 14,335,200 |
immunovant inc | 13,143,300 |
pepgen inc | 12,101,800 |
compass pathways plc | 11,714,200 |
Ticker | % Inc. |
---|---|
uniqure nv | 8,936 |
xencor inc | 317 |
replimune group inc | 82.13 |
stryker corporation | 48.7 |
cg oncology inc | 26.57 |
arvinas inc | 19.84 |
neurogene inc | 18.94 |
akero therapeutics inc | 15.89 |
Ticker | % Reduced |
---|---|
essa pharma inc | -65.87 |
masimo corp | -53.28 |
sage therapeutics inc | -46.31 |
taysha gene therapies inc | -41.98 |
acadia pharmaceuticals inc | -36.49 |
immatics n.v | -34.59 |
bruker corp | -28.73 |
dyne therapeutics inc | -23.47 |
Ticker | $ Sold |
---|---|
geron corp | -200,268,000 |
sab biotherapeutics inc | -1,715,240 |
10x genomics inc | -11,354,500 |
tempus ai inc | -22,640,000 |
glaukos corp | -50,326,000 |
RTW INVESTMENTS, LP has about 86.4% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 86.4 |
Others | 13.6 |
RTW INVESTMENTS, LP has about 13.6% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
MID-CAP | 51.8 |
SMALL-CAP | 18.2 |
UNALLOCATED | 15.7 |
LARGE-CAP | 13.6 |
About 59.2% of the stocks held by RTW INVESTMENTS, LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 56 |
Others | 40.8 |
S&P 500 | 3.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
RTW INVESTMENTS, LP has 72 stocks in it's portfolio. About 48.6% of the portfolio is in top 10 stocks. RNA proved to be the most loss making stock for the portfolio. MDGL was the most profitable stock for RTW INVESTMENTS, LP last quarter.
Last Reported on: 14 Feb, 2025Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
ACAD | acadia pharmaceuticals inc | 2.42 | 8,705,500 | 159,746,000 | reduced | -36.49 | ||
AGLE | spyre therapeutics inc | 1.27 | 3,622,000 | 84,320,100 | added | 11.16 | ||
AKRO | akero therapeutics inc | 2.89 | 6,859,820 | 190,840,000 | added | 15.89 | ||
ALKS | alkermes plc | 3.29 | 7,557,840 | 217,363,000 | added | 13.58 | ||
ARVN | arvinas inc | 0.97 | 3,334,310 | 63,918,700 | added | 19.84 | ||
AXSM | axsome therapeutics inc | 5.18 | 4,051,360 | 342,786,000 | reduced | -3.3 | ||
BRKR | bruker corp | 2.20 | 2,481,120 | 145,443,000 | reduced | -28.73 | ||
CGEM | cullinan therapeutics inc | 0.31 | 1,705,960 | 20,778,600 | unchanged | 0.00 | ||
CMPS | compass pathways plc | 0.18 | 3,098,990 | 11,714,200 | new | |||
CNTA | centessa pharmaceuticals plc | 0.01 | 50,000 | 837,500 | unchanged | 0.00 | ||
CRVS | corvus pharmaceuticals inc | 0.22 | 2,679,480 | 14,335,200 | new | |||
CYTK | cytokinetics inc | 1.94 | 2,721,160 | 128,003,000 | unchanged | 0.00 | ||
DYN | dyne therapeutics inc | 1.86 | 5,218,640 | 122,951,000 | reduced | -23.47 | ||
EPIX | essa pharma inc | 0.03 | 1,113,000 | 1,992,270 | reduced | -65.87 | ||
ESTA | establishment labs hldgs inc | 1.79 | 2,569,690 | 118,385,000 | reduced | -2.87 | ||
ETNB | 89bio inc | 0.88 | 7,478,060 | 58,478,400 | added | 1.35 | ||
GERN | geron corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
GKOS | glaukos corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
GMED | globus med inc | 1.22 | 972,000 | 80,394,100 | new | |||
IDYA | ideaya biosciences inc | 0.08 | 200,000 | 5,140,000 | unchanged | 0.00 | ||